Proteinase K Global Market Size, Share, Trend Analysis, By Form, By Application, By End User, By Region And Segment Forecasts, 2024-2033 | Merck KGaA, QIAGEN NV, Codexis Inc., Amicogen Inc.

Spread the love

The Proteinase K Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Proteinase K Market:
https://www.thebusinessresearchcompany.com/report/proteinase-k-global-market-report

According to The Business Research Company’s Proteinase K Global Market Report 2024, The proteinase k market size has grown rapidly in recent years. It will grow from $4.47 billion in 2023 to $4.92 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to expanding biotechnology and life sciences research, diagnostic testing advancements, pharmaceutical development needs, bioprocessing and protein purification, quality control in food and beverages.

The proteinase k market size is expected to see rapid growth in the next few years. It will grow to $7.22 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to continued growth in molecular diagnostics, advancements in precision medicine, biopharmaceutical manufacturing expansion, research in proteomics and genomics, increased application in forensic sciences. Major trends in the forecast period include pharmaceutical industry growth, technological advancements, market competition and pricing, sustainable and animal-free variants, global pandemic impact.

An increasing prevalence of chronic diseases is expected to propel the growth of the proteinase K market going forward. Chronic disease is a condition or illness that lasts more than a year and requires ongoing medical treatment. Proteinase K is used in chronic diseases in a preventative or therapeutic role to extract and isolate the DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) of viruses that cause various chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, an increasing prevalence of chronic diseases will drive the proteinase K market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10837&type=smp

The proteinase k market covered in this report is segmented –
1) By Form: Lyophilized Powder Form, Liquid Form
2) By Therapeutic Area: Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Neurology, Other Therapeutic Areas
3) By Application: Isolation And Purification Of Genomic DNA And RNA, In Situ Hybridization, Mitochondria Isolation, Enzyme Removal
4) By End-Use: Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories

Product innovation is a key trend gaining popularity in the proteinase K market. Major companies in the proteinase K market are launching innovative products to sustain their position in the proteinase K market. For instance, Biocatalysts Ltd., a UK-based biotechnology company, launched Proteocut K, a high-quality, cost-effective alternative to liquid proteinase K. The innovative enzyme subtilisin-type serine protease with broad substrate specificity can be used in a range of life science applications. Proteinase K is a subtilisin-type serine endopeptidase with a broad pH profile and substrate specificity, enabling it to hydrolyze various proteins efficiently and effectively. The serine endopeptidase protects K has an activity of about 1,450 U/ml (Hemoglobin assay), is active throughout a broad pH (6.0 – 10.0) and temperature (40 -70°C) range, and can be employed in a variety of life science applications.

The proteinase k market report table of contents includes:
1. Executive Summary